Skip to main content
. 2021 Aug 10;2021(8):CD010037. doi: 10.1002/14651858.CD010037.pub3

Yanovski 2009.

Study characteristics
Methods Randomised controlled trial
Participants Men and women 18 years or older. The trial was conducted in the United States of America. 
Interventions Intervention: Calcium supplement (calcium carbonate 1500 mg/day) 
Comparator: Placebo capsules  with no calcium
Outcomes Primary: Body weight
Secondary: triceps skinfold fold thickness, body circumferences and DXA percentage fat.
 
Notes 23% reported dietary calcium intake less than 600 mg/d and 75% reported dietary calcium intake less than the U.S. dietary reference intake for persons age 51 to 70 years (1200 mg/d).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk The National Institutes of Health Clinical Center Pharmaceutical Development Section used permuted blocks with stratification to generate the alloca‐ tions that translated code numbers into study group assign‐ ments by using a pseudo‐random number program.
Allocation concealment (selection bias) Low risk The Pharmaceutical Development Section prepared placebo and calcium capsules to appear identical. Pharmacy personnel, not otherwise involved with the conduct of the study, dispensed study capsules with medication placed in con‐ tainers that appeared identical and differed only by the individual participant code number.
Blinding of participants and personnel (performance bias)
All outcomes Low risk No participant, investigator, or other medical or nursing staff interacting with participants was aware of study group assignments for the duration of the trial.
Blinding of outcome assessment (detection bias)
All outcomes Low risk No participant, investigator, or other medical or nursing staff interacting with participants was aware of study group assignments for the duration of the trial.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No information presented in the article
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk No baseline or crude data reported